(Q47356302)

14 January 2018

title

Vaccine adjuvant: it makes the difference (English)

1 reference

14 January 2018

author name string

Karla M Lima

1

1 reference

14 January 2018

Sandra Aparecida dos Santos

2

1 reference

14 January 2018

José M Rodrigues

3

1 reference

14 January 2018

Célio L Silva

4

1 reference

14 January 2018

language of work or name

English

0 references

publication date

1 June 2004

1 reference

14 January 2018

published in

Vaccine

1 reference

14 January 2018

volume

22

1 reference

14 January 2018

issue

19

1 reference

14 January 2018

page(s)

2374-2379

1 reference

14 January 2018

Manipulating the immune system: humoral versus cell-mediated immunity

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.030

Dendritic cells at the end of the millennium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.030

Vaccine adjuvants: role and mechanisms of action in vaccine immunogenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.030

Adjuvants--a classification and review of their modes of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.030

Vaccine adjuvant technology: from mechanistic concepts to practical applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.030

Cutting edge: different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.030

Immunoregulatory activity of CpG oligonucleotides in humans and nonhuman primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.030

Adjuvant formulations and delivery systems for DNA vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.030

Reproductive toxicity testing of vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.030

What are the limits of adjuvanticity?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.030

Immunology of tuberculosis and implications in vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.030

Mycobacterium leprae 65hsp antigen expressed from a retroviral vector in a macrophage cell line is presented to T cells in association with MHC class II in addition to MHC class I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.030

Comparison of different delivery systems of vaccination for the induction of protection against tuberculosis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.030

Cytotoxic T cells and mycobacteria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.030

Efficacy of DNA-hsp65 vaccination for tuberculosis varies with method of DNA introduction in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.030

Role of trehalose dimycolate in recruitment of cells and modulation of production of cytokines and NO in tuberculosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.030

Single dose of a vaccine based on DNA encoding mycobacterial hsp65 protein plus TDM-loaded PLGA microspheres protects mice against a virulent strain of Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.030

10.1016/J.VACCINE.2003.12.030

7 January 2021

Identifiers

DOI

1 reference

14 January 2018

1 reference

14 January 2018